CAS: 1786438-30-9

(R)-CR8 trihydrochloride

(R)-CR8 is an analog of the natural amino acid L-cysteine. In vivo, (R)-CR8 is converted to cysteine, which functions as a precursor for other important biological molecules, such as glutathione, taurine and S-adenosylmethionine. (R)-CR8 has been shown to protect neurons from apoptotic cell death induced by chronic exposure to high levels of glutamate or oxygen deprivation. It also has neuroprotective properties in vivo in an animal model of Parkinson's disease. The pharmacokinetic properties of (R)-CR8 have been studied in vivo and in vitro human cells, and it has been shown to be well tolerated when administered orally at doses up to 1 g/kg body weight. (R)-CR8 has also demonstrated efficacy against cancer cells in vitro and in vivo models. This compound is being developed as a potential therapeutic agent for the treatment of neurodegenerative diseases and cancer.

(R)-CR8 trihydrochloride (CR8, (R)-Isomer trihydrochloride) is a CDK1/2/5/7/9 inhibitor with neuroprotective activity that induces apoptosis.